NAUT·63909J108·US·equity·Healthcare - Biotechnology-Activist
NAUT (NAUTILUS BIOTECHNOLOGY INC) is held by 42 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($4.9M), GEODE CAPITAL MANAGEMENT, LLC ($2.3M), GOLDMAN SACHS GROUP INC ($1.5M). Net institutional sentiment: Mixed.
See how NAUT's score breaks down across 4 SEC sources
Showing 1-20 of 48
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer